Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese

Journal of Autoimmunity

Volumn 9, Issue 1, 1996, Pages 105-111

  Kasuga, A ^a,b,f   Maruyama, T ^c   Ozawa, Y ^a   Takei, I ^a   Falorni, A ^d   Lernmark, A ^d,e   Saruta, T ^a  

^a KEIO UNIVERSITY   (Japan)

^b Tokyo Denryoku Hospital   (Japan)

^c Social Insurance Saitama Chuo Hosp   (Japan)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF WASHINGTON   (United States)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Autoimmunity; Glutamic acid decarboxylase; Non insulin dependent diabetes mellitus

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; INSULIN; ISOENZYME;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; ADOLESCENT; AGE; BLOOD; CHILD; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AUTOANTIBODIES; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; ISOENZYMES; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0029665614     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0013     Document Type: Article

References (34)

1. Olansky L., Welling C., Giddings S., Adler S, Bourey R., Dowse G., Serjeanston S., Zimmet P., Permutt M.A. 1992. A variant insulin promoter in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89: 1596-1602
2. Yosimasa Y., Seino S., Whittaker J., Kakehi T., Kosaki A., Kuzuya H., Imura H., Bell G.I., Steiner D.F. 1986. Insulin-resistant Diabetes due to a point mutation that presents insulin proreceptor processing. Science 240: 784-787
3. Kadowaki T., Bevins C.L., Cama A., Ojamaa K., Marcus-Samuels B., Kadowaki H., Beitz L., McKeon C., Taylor S.I. 1986. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240: 787-790
4. Frouguel Ph., Vaxillaire M., Sun F., Velho G., Zouali H., Butel M.O., Lesage S., Vionnet N., Clement K., Fougerousse F., Tanizawa Y., Weissenbach J., Beckmann J.S., Lathrop G.M., Passa Ph., Permutt M.A., Cohen D. 1992. Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin-dependent diabetes mellitus. Nature 356: 162-164
5. Hager J., Hansen L., Vaisse C., Vionnet N., Philippi A., Poller W., Velho G., Carcassi C., Contu L., Julier C., Cambien F., Passa P., Lathrop M., Kindsvogel W., Demenais F., Nishimura E., Froguel P. 1995. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nature Genetics 9: 299-304
6. Reardon W., Ross R.J.M., Sweeney M.G., Luxon L.M., Pembrey M.E., Harding A.E., Trembath R.C. 1992. Diabetes associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376-1379
7. Lebovitz H.R. 1994. Oral Antidiabetic Agents. In Joslin's Diabetes Mellitus, 13th edn. C.R. Kahn and G.C. Weir, eds. Lea and Febiger, Pennsylvania, pp. 515-516
8. Groop L.C., Pelkonen R., Koslimies S., Bottazzo G.F., Doniach D. 1986. Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes care 9: 129-133
9. Kitagawa T., Owada M., Mano T., Fujita H. 1982. The epidemiology of childhood diabetes in Japan. In Clinico-Genetic Genesis of Diabetes Mellitus. G. Mimura, S. Baba, Y. Goto, and J. Koebbering, eds. Excerpta Med., Amsterdam, pp. 51-57
10. Matsuda A., Kuzuya T. 1985. Analysis on clinical characteristics of late onset type I diabetes (in Japanese). J. Jpn. Diabetes Soc. 28: 1331-1333
11. Groop L.C., Bottazzo G.F., Doniach D. 1986. Islet cell antibodies identify latent type I diabetes in patients aged 37-75 years at diagnosis. Diabetes 35: 237-241
12. Kobayashi T., Itoh T., Kosaka K., Sato K., Tsuji K. 1987. Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of Type I diabetes. Diabetes 36: 510-517
13. Tuomi T., Groop L.C., Zimmet P.Z., Rowley M.J., Knowles W., Mackay I.R. 1993. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42: 359-362
14. Gottsaeter A., Lernmark A., Landin-Olsson M., Sundkvist G., Fernlund P. 1993. β-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes care 16: 902-910
15. Hagopian W.A., Karlsen A.E., Gottsaeter A., Landin-Olsson M.L., Grubin C.E., Sundkvist G., Petersen J.S., Boel E., Dyrberg T., Lernmark A. 1993. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 91: 368-374
16. Zimmet P.Z., Tuomi T., Mackay I.R., Rowley M.J., Knowles W., Cohen M., Lang D.A. 1994. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic medicine 11: 299-303
17. Yamada N., Gotoda T., Yoshinaga H., Ohashi T., Sakurai N., Yazaki Y., Shimano H., Kosaka K. 1994. Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance. Diabetes Care 17: 107-114
18. Kobayashi T., Kajio H., Tamemoto K., Sugimoto T., Nakanishi K., Murase T., Kato N., Kosaka K., Okubo M. 1993. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16: 780-788
19. Atkinson M.A., Maclaren N.K. 1994. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331: 1428-1436
20. Falorni A., Grubin C.E., Takei I., Shimada A., Kasuga A., Maruyama T., Ozawa Y., Kasatani T., Saruta T., Li L., Lernmark A. 1994. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamate decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19: 113-125
21. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057
22. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark A. 1994. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood type 1 diabetes. Diabetologia 37: 344-350
23. Karlsen A.E., Hagopian W.A., Grubin C.E., Dube S., Disteche C.M., Adler D.A., Barmeier H., Mathewes S., Grant F.J., Foster D., Lernmark A. 1991. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl. Acad. Sci. USA 88: 8337-8341
24. Schmidli R.S., Colman P.G., Bonifacio E., Bottazzo G.F., Harrison L.C., participating laboratories. 1994. High level of concordance between assays for glutamic acid decarboxylase antibodies: the first international Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 43: 1005-1009
25. Landin-Olsson M., Nilsson K.O., Lernmark A., Sundkvist G. 1990. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes Mellitus. Diabetologia 33: 561-568
26. Bonifacio E., Lernmark A., Dawkins R.L. 1988. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J. Immunol. Methods 106: 83-88
27. Groop L., Miettinen A., Groop P.H., Meri S., Koskimies S., Bottazzo G.F. 1988. Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with Type II diabetes. Diabetes 37: 99-103
28. Palmer J.P., McCulloch D.K. 1991. Prediction and prevention of IDDM-1991. Diabetes 40: 943-947
29. Kawasaki E., Takino H., Yano M., Uotani S., Matsumoto K., Takao Y., Yamaguchi Y., Akazawa S., Nagataki S. 1994. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86
30. Leu(UUR) gene mutation in Japanese patients. Diabetologia 37: 504-510
31. Otabe S., Sakura H., Shimokawa K., Mori Y., Kadowaki H., Yasuda K., Nonaka K., Hagura R., Akanuma Y., Yazaki Y., Kadowaki T. 1994. The high prevalence of the diabetic patients with a mutation in the mitochondrial gene in Japan. J. Clin. Invest. 79: 768-771
32. Oka Y., Katagiri H., Yazaki Y., Murase T., Kobayashi T. 1993. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 342: 527-538
33. Seissler J., Amann J., Mauch L., Haubruck H., Wolfahrt S., Beig S., Richter W., Holl R., Heinze E., Northemann W., Scherbaum A. 1993. Prevalence of autoantibodies to the 65-and 67-kD isoform of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 92: 1394-1399
34. Gorus F.K., Vandewalle C.L., Dorchy H., Crombrugge P.V., Schuit F.C., Pipellers D.G., The Belgian Diabetes Registry. 1994. Influence of age on the association among insulin autoantibodies, islet cell antibodies, and HLA DQA1*0301-DQB1*0302 in sibling of patients with type 1 (insulin-dependent) diabetes Mellitus. J. Clin. Endocrinol. Metab. 78: 1172-1178